GlobeNewswire: Amedisys, Inc. Contains the last 10 of 268 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T08:53:10ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/21/2833170/0/en/Amedisys-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results.html?f=22&fvtc=4&fvtv=21279Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results2024-02-21T21:30:11Z<![CDATA[BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.]]>https://www.globenewswire.com/news-release/2024/02/08/2825920/0/en/Amedisys-Offers-Molecular-Testing-for-Rapid-and-Accurate-Infection-Diagnosis.html?f=22&fvtc=4&fvtv=21279Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis2024-02-08T12:30:00Z<![CDATA[BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing to its care centers nationwide. This innovative collaboration with Patient Choice Laboratories utilizes molecular testing for the swift and precise identification of pathogens in urine, respiratory and wound infections. By leveraging the latest in diagnostic technology, Amedisys aims to improve the quality of infection testing, ultimately facilitating better patient care and outcomes.]]>https://www.globenewswire.com/news-release/2023/10/24/2766070/0/en/Amedisys-Reports-Third-Quarter-2023-Financial-Results.html?f=22&fvtc=4&fvtv=21279Amedisys Reports Third Quarter 2023 Financial Results2023-10-24T20:30:36Z<![CDATA[BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.]]>https://www.globenewswire.com/news-release/2023/10/18/2762768/0/en/Amedisys-Celebrates-National-Quality-Week.html?f=22&fvtc=4&fvtv=21279Amedisys Celebrates National Quality Week2023-10-18T20:30:00Z<![CDATA[Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care]]>https://www.globenewswire.com/news-release/2023/08/31/2735146/0/en/Amedisys-Recognizes-Suicide-Prevention-Awareness-Month-and-Promotes-the-988-Suicide-Crisis-Lifeline.html?f=22&fvtc=4&fvtv=21279Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline2023-08-31T11:30:00Z<![CDATA[BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suicide Prevention Awareness Month and join the efforts to raise awareness for suicide prevention and mental health. In support of this important cause, Amedisys is highlighting the 988 Suicide and Crisis Lifeline which makes it easier for individuals in crisis to access crucial resources and assistance.]]>https://www.globenewswire.com/news-release/2023/07/26/2711713/0/en/Amedisys-Reports-Second-Quarter-2023-Financial-Results.html?f=22&fvtc=4&fvtv=21279Amedisys Reports Second Quarter 2023 Financial Results2023-07-26T20:30:17Z<![CDATA[BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.]]>https://www.globenewswire.com/news-release/2023/06/26/2694471/0/en/Amedisys-and-Optum-to-Combine-Advancing-Value-Based-Care-for-Patients.html?f=22&fvtc=4&fvtv=21279Amedisys and Optum to Combine, Advancing Value-Based Care for Patients 2023-06-26T12:58:57Z<![CDATA[BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agreed to combine. The agreement calls for the acquisition of Amedisys’s outstanding common stock in an all-cash transaction for $101 per share.]]>https://www.globenewswire.com/news-release/2023/06/05/2681937/0/en/Amedisys-Announces-Receipt-of-Unsolicited-Proposal-From-Optum.html?f=22&fvtc=4&fvtv=21279Amedisys Announces Receipt of Unsolicited Proposal From Optum2023-06-05T12:13:31Z<![CDATA[Amedisys Board Determines Optum Proposal Could Reasonably be Expectedto Result in a Superior Proposal]]>https://www.globenewswire.com/news-release/2023/04/20/2650940/0/en/Amedisys-Announces-First-Quarter-2023-Earnings-Release-and-Conference-Call-Date.html?f=22&fvtc=4&fvtv=21279Amedisys Announces First Quarter 2023 Earnings Release and Conference Call Date2023-04-20T12:00:00Z<![CDATA[BATON ROUGE, La., April 20, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, will report results for the first quarter ended March 31, 2023, after the market closes on May 3, 2023. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 4, 2023.]]>https://www.globenewswire.com/news-release/2023/03/23/2633715/0/en/Amedisys-Supports-New-Research-that-Demonstrates-the-Value-of-Hospice-Care-Through-Better-Outcomes-and-Medicare-Savings.html?f=22&fvtc=4&fvtv=21279Amedisys Supports New Research that Demonstrates the Value of Hospice Care Through Better Outcomes and Medicare Savings2023-03-23T22:11:00Z<![CDATA[BATON ROUGE, La., March 23, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, supports the findings from the NORC at the University of Chicago study released by the National Association for Home Care & Hospice (NAHC) and the National Hospice and Palliative Care Organization (NHPCO) today that demonstrates the value of hospice care.]]>